These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17523184)

  • 1. Channelling of SSRIs and SNRIs use in the Tayside population, Scotland.
    Wei L; Chen R; MacDonald TM
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):859-66. PubMed ID: 17523184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters.
    Sclar DA; Robison LM; Skaer TL; Galin RS
    Int J Psychiatry Med; 1998; 28(4):407-19. PubMed ID: 10207740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
    Revol R; Rault C; Polard E; Bellet F; Guy C
    Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants.
    Montgomery SA
    CNS Spectr; 2008 Jul; 13(7 Suppl 11):27-33. PubMed ID: 18622372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital.
    Nakao M; Takeuchi T; Yano E
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):30-5. PubMed ID: 17256448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs.
    Giorlando F; Teister J; Dodd S; Udina M; Berk M
    Curr Drug Saf; 2013 Jul; 8(3):175-80. PubMed ID: 23841535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSRI/SNRI Use is Not Associated with Increased Risk of Delayed Cerebral Ischemia After aSAH.
    Young JB; Singh TD; Rabinstein AA; Fugate JE
    Neurocrit Care; 2016 Apr; 24(2):197-201. PubMed ID: 26264066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
    Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC
    Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common mental health diagnoses arising from or coinciding with menopausal transition and prescribing of SSRIs/SNRIs medications and other psychotropic medications.
    Alsugeir D; Adesuyan M; Talaulikar V; Wei L; Whittlesea C; Brauer R
    J Affect Disord; 2024 Nov; 364():259-265. PubMed ID: 39142573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.
    Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA
    Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of SSRI and SNRI therapies for depression.
    Weilburg JB
    Manag Care; 2004 Jun; 13(6 Suppl Depression):25-33. PubMed ID: 15293768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.